Apexigen is a company that develops antibody-based therapeutics for the treatment of cancer with a focus on immuno-oncology. Its lead product reverses the systemic immune suppression that typically affects cancer patients, through the activation of several mechanisms of immune functionality, enabling clinical researchers to find solutions for cancer immunity.